Risk Assessment in Nanomedicine. Needs for harmonisation, standardisation and validation

Arrangement: Nano to Clinic – Synergies for Clinical Translation of Nanotechnology in Cancer Therapies (Zagreb, Croatia)

Dato: 3. mars 2023